Treatments for restoring hair on bald women or women with thinning hair are not very common. However, all the research that is done, which relates to specifically men in the end, have provided valuable information for women as well. Usually, by reason of deduction, scientists are discovering that women’s hair loss is much more complex to understand.
Female pattern hair loss is usually diagnosed by ruling out other causes rather than ruling in certain indications. One of the main causes that a doctor will check for is an increased level of testosterone in you system. Some symptoms of this are abnormal hair growth such growth such as on the face or on the abdomen below the navel or changes in the menstrual cycle. This is usually caused by medications that contain testosterone. Other tests that your doctor may run could include blood tests to rule out illnesses that may be causing the hair loss as a symptom. One test that does not indicate anything about hair loss is analyzing the hair itself. It may detect lead or arsenic poisoning but that’s all.
Currently the only treatment that has been approved for female hair loss is 2% Rogaine (Minoxidil). This is the only medication that has received FDA approval for women. The Rogaine prescribed for men is 2.5 and 5 % and not recommended for women to handle. Studies show that this treatment may help up to 25% of women with hair loss disease. For women with hair loss that do not respond to the Rogaine treatments, there is a complimentary drug that has NOT been approved yet by FDA that when added to the Rogaine treatments may work. Either way, the treatments are expensive because as soon as the treatments stop, hair loss begins again.
Androgenetic alopecia is a serious problem for many women. Millions of women worldwide have turned to Ovation Cell Therapy as their treatment for choice when they notice their hair thinning.
The active ingredient in Ovation products is Panthenol, which is a widely used pro-vitamin in the beauty industry and is a natural constituent of healthy hair. Research shows that this ingredient does have a moisturizing effect and can repair hair damage, giving the hair extra body and shine, but whether it grows new hair is an open question.
As a result, many women have been disappointed by the results of Ovation Cell Therapy. But now they may have a more effective alternative: Spectral DNC and Spectral F7, both produced by DS Laboratories.
The advantage of these new products is that at least they contain ingredients that have been proven to regrow hair. In the case of Spectral DNC, those ingredients are a potent 4.5% solution of Minoxidil and Aminexil SP94.
If you are not familiar with these two ingredients, Minoxidil is the active ingredient used in Rogaine® and Aminexil SP94, recently discovered by L’oreal after 10 years of extensive research, is the active ingredient used in L’oreal’s new hair regrowth solution. Both of these ingredients have been tested in hundreds of clinical studies on thousands of volunteers and have been shown effective in the treatment of hair loss. However, studies indicate that some people react better to one ingredient than the other. Moreover, unlike Rogaine that mixes minoxidil with ethanol (alcohol) and propylene glycol, Spectral DNC couples minoxidil with retinol (a vitamin-A derived substance).
Spectral.F7 is the brand-new topical hair regrowth serum just released by DS Laboratories that is based on the newly discovered peptide, Astressin-B, that so dramatically regrew hair on bald mice. Divine Skin becomes the first biotech developer to synthesize and commercialize the peptide for human use in a cosmetic product, to be marketed as Spectral.F7 under the DS Laboratories brand.
Astressin-B sparked extensive media coverage worldwide and excitement around the biotech industry after a clinical study, conducted by the University of California Los Angeles and the Veterans Administration, was published in February. By applying the peptide (a protein fragment) subcutaneously to mice that had gone bald due to overexpression of stress hormones, scientists showed that astressin-B blocked receptors for corticotropin-releasing factor, involved in the stress response, and led to hair regrowth. This technology is years ahead of its time. It could provide significant benefits to many women who suffer from hair loss.